Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check26 days agoChange DetectedA site-wide notice says NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.4%

- Check33 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the software revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check40 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check61 days agoChange DetectedThe revision history now shows a new site revision v3.7.0 and removes the earlier v3.6.6 entry, updating the page's versioning trail. This is a metadata update to the page's history and does not affect the study data or functionality.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision label on the page updates from v3.6.5 to v3.6.6, indicating a new version of the study history page. This change is a metadata update and does not modify the actual study data or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.